Just M
Schweiz Med Wochenschr. 1978 Nov 11;108(45):1763-8.
Cost-benefit analyses have been performed in investigating the usefulness of general vaccination against measles and mumps in all children. Even by a conservative reckoning the cost of general measles immunization for all children in the second year of life is much lower than the financial effects of the disease. In the case of general mumps vaccination, cost-benefit analyses fo not give so significant an outweight of financial benefit as for measles vaccination. If only for economic reasons, however, general immunization against mumps is recommended for all children in the second year of life. From the economic viewpoint, general immunization programs for teenagers do not pay either with regard to mumps or measles. Such vaccinations may of course be recommended on an individual basis, especially for teenagers with a negative measles history.
已经进行了成本效益分析，以研究对所有儿童进行麻疹和腮腺炎常规疫苗接种的效用。即使按照保守的计算方法，对所有一岁儿童进行麻疹常规免疫接种的成本也远低于该疾病造成的经济影响。就腮腺炎常规疫苗接种而言，成本效益分析并未显示出像麻疹疫苗接种那样显著的经济效益。然而，仅出于经济原因，建议对所有一岁儿童进行腮腺炎常规免疫接种。从经济角度来看，青少年的常规免疫计划在腮腺炎或麻疹方面都不划算。当然，这种疫苗接种可以根据个人情况推荐，特别是对于麻疹病史为阴性的青少年。
